- Home
- MOGO vs VRCA Comparison
MOGO vs VRCA Comparison
Compare MOGO & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOGO
- VRCA
- Stock Information
- Founded
- MOGO 2003
- VRCA 2013
- Country
- MOGO Canada
- VRCA United States
- Employees
- MOGO N/A
- VRCA N/A
- Industry
- MOGO
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- MOGO
- VRCA Health Care
- Exchange
- MOGO Nasdaq
- VRCA Nasdaq
- Market Cap
- MOGO 42.5M
- VRCA 40.6M
- IPO Year
- MOGO N/A
- VRCA 2018
- Fundamental
- Price
- MOGO $2.01
- VRCA $4.63
- Analyst Decision
- MOGO Strong Buy
- VRCA Hold
- Analyst Count
- MOGO 1
- VRCA 5
- Target Price
- MOGO $4.00
- VRCA $60.00
- AVG Volume (30 Days)
- MOGO 269.9K
- VRCA 520.1K
- Earning Date
- MOGO 11-05-2025
- VRCA 11-03-2025
- Dividend Yield
- MOGO N/A
- VRCA N/A
- EPS Growth
- MOGO N/A
- VRCA N/A
- EPS
- MOGO 0.12
- VRCA N/A
- Revenue
- MOGO $30,265,570.00
- VRCA $14,704,000.00
- Revenue This Year
- MOGO $61.97
- VRCA $332.45
- Revenue Next Year
- MOGO $4.03
- VRCA $12.85
- P/E Ratio
- MOGO $16.74
- VRCA N/A
- Revenue Growth
- MOGO 0.18
- VRCA 5.72
- 52 Week Low
- MOGO $0.74
- VRCA $3.82
- 52 Week High
- MOGO $3.83
- VRCA $17.38
- Technical
- Relative Strength Index (RSI)
- MOGO 58.62
- VRCA 48.70
- Support Level
- MOGO $1.77
- VRCA $4.17
- Resistance Level
- MOGO $2.07
- VRCA $4.75
- Average True Range (ATR)
- MOGO 0.11
- VRCA 0.34
- MACD
- MOGO 0.01
- VRCA 0.06
- Stochastic Oscillator
- MOGO 70.00
- VRCA 69.04
About MOGO Mogo Inc.
Mogo Inc is a Canadian-based financial technology company. It offers a finance application to consumers with solutions that help them to control their financial health. At Mogo, users can sign up for a free account and get access to products and solutions that help users to monitor their credit score, protect themselves from identity fraud, control their spending, and borrow responsibly. Company offers digital loans and mortgages and also offer a digital payments platform that powers next-generation card programs for both established world-wide corporations and fintech companies in Europe and Canada.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.